SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
February 10, 2021
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
|France|| ||001-36153|| ||Not Applicable|
|(State or other jurisdiction|
| ||(I.R.S. Employer|
|32 Rue Blanche||Paris||France|| ||75009|
|(Address of principal executive offices)|| ||(Zip Code)|
+33 14 040 2290
Registrant’s telephone number, including area code
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|☐||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|☐||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|☐||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-(b))|
|☐||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-(c))|
Securities registered pursuant to Section 12(b) of the Act:
|Title of each class||Trading Symbol(s)||Name of each exchange on which registered|
|American Depositary Shares, each representing one ordinary share, nominal value €0.025 per share||CRTO||Nasdaq Global Select Market|
|Ordinary Shares, nominal value €0.025 per share*||Nasdaq Global Select Market|
*Not for trading, but only in connection with the registration of the American Depositary Shares.
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. c
|ITEM 2.02|| Results of Operations and Financial Condition|
On February 10, 2021, Criteo S.A. (the “Company”) issued a press release and will hold a conference call regarding its financial results for the quarter and year ended December 31, 2020. A copy of the press release is furnished as Exhibit 99.1 to this report.
The information furnished with this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
The Company is making reference to non-GAAP financial information in both the press release and the conference call. A reconciliation of these non-GAAP financial measures to the most comparable GAAP financial measures is contained in the attached Exhibit 99.1 press release.
Criteo today announces that the Board of Directors has authorized a share repurchase program of up to $100 million of the Company’s outstanding American Depositary Shares.The Company intends to use any repurchased shares under this new authorization to satisfy employee equity obligations in lieu of issuing new shares, which would limit future dilution for its shareholders.
Under the terms of the authorization, the stock purchases may be made from time to time in the open market, in privately negotiated purchases, or in such manner as determined by the Company, in compliance with applicable state and federal securities laws and applicable provisions of French corporate law. The timing and amounts of any purchases will be based on market conditions and other factors such as, for example, price, regulatory requirements and capital availability, as determined by Criteo’s management team. The authorization does not require the purchase of any minimum number of shares and may be suspended, modified or discontinued at any time without prior notice.
|ITEM 9.01|| Financial Statements and Exhibits. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|Date: February 10, 2021||By:||/s/ Sarah Glickman|
|Title:|| Chief Financial Officer|